David H. Aggen
- Oncology top 5%
- Molecular Biology
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Co-authors
- Charles G. DrakeDavid M. KranzAdam S. ChervinJennifer D. StoneBrian I. RiniRam S. MohanPhilip D. GreenbergSarah A. Richman
- Topics
- Cancer Immunotherapy and Biomarkers (27 papers)Bladder and Urothelial Cancer Treatments (24 papers)CAR-T cell therapy research (13 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesSpainCanada
In The Last Decade
David H. Aggen
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Oncology 663
- Molecular Biology 459
- Immunology 427
- Pulmonary and Respiratory Medicine 348
- Surgery 198
Countries citing papers authored by David H. Aggen
This map shows the geographic impact of David H. Aggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Aggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Aggen more than expected).
Fields of papers citing papers by David H. Aggen
This network shows the impact of papers produced by David H. Aggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Aggen. The network helps show where David H. Aggen may publish in the future.
Co-authorship network of co-authors of David H. Aggen
This figure shows the co-authorship network connecting the top 25 collaborators of David H. Aggen. A scholar is included among the top collaborators of David H. Aggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Aggen. David H. Aggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 15 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 105 | |
| 11 | 191 | |
| 12 | 35 | |
| 13 | 92 | |
| 14 | 17 | |
| 15 | 136 | |
| 16 | 24 | |
| 17 | 1 | |
| 18 | 18 | |
| 19 | 42 | |
| 20 | 49 |
About David H. Aggen
David H. Aggen is a scholar working on Oncology, Immunology and Biological Psychiatry, having authored 62 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Bladder and Urothelial Cancer Treatments (24 papers) and CAR-T cell therapy research (13 papers). The work is most often cited by research in Oncology (663 citations), Immunology (427 citations) and Cancer Research (174 citations). David H. Aggen has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Charles G. Drake, David M. Kranz, Adam S. Chervin, Jennifer D. Stone, Brian I. Rini, Ram S. Mohan, Philip D. Greenberg, Sarah A. Richman, Nivedita Chowdhury and Aleksandar Obradović. Their work appears in journals such as Cell, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.